A Study of PTS100 in Primary HCC Patients

Clinical trial NCT03447951 · UNKNOWN

Trial details

NCT number: NCT03447951
Sponsor: Gongwin Biopharm Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2018-06-19
Primary completion: 2024-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.